Maxcyte Inc (MXCT)

R&D Expense Growth

10.27%

Quarterly · Period ending:

MXCT logo

MXCT R&D Expense Growth

Latest reported10.27%
MXCT Quarterly R&D Growth (QoQ) (0.00% → 10.27%)
High-resolution chart · PNG

MXCT r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Maxcyte Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
10.267%
15.6522%
-37.2649%
-15.2018%
6.2002%
27.9367%
-13.2054%
-5.3924%
-15.858%
14.3082%
-6.7353%
10.5932%
-6.3337%
5.5691%
7.5661%
13.3965%
24.7178%
11.3665%
23.0842%
-14.2639%
-47.2722%
24.2216%
8.2693%
10.4513%
-3.6351%
7.6188%
-0.2251%
-18.4507%
0%
53.1281%
0%
28.8762%
0%
-30.7309%
0%
69.16%
0%
58.6003%
0%
28.7691%
0%
30.8914%
0%
8.9394%
0%
13.2285%
0%
4.3325%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.